How to Define Patient Selection, Selection of Optimal Intervention Points & Therapeutic Outcomes Using Biomarkers & “Prodromal AD”

Time: 11:20 am
stream: Stream one
day: Track B - Day 1 AM


  • Learning tips and tricks to streamline the use of “biomarkers” for patient selection
  • Using longitudinal biomarker measures of high scientific interest in the field to augment the use of ‘clinical/cognitive efficacy” outcomes
  • Uncovering data driven methods to optimize the selection of patient and protocol duration and endpoints